array:23 [
  "pii" => "S1578219017301853"
  "issn" => "15782190"
  "doi" => "10.1016/j.adengl.2017.04.003"
  "estado" => "S300"
  "fechaPublicacion" => "2017-09-01"
  "aid" => "1678"
  "copyright" => "Elsevier España, S.L.U. and AEDV"
  "copyrightAnyo" => "2017"
  "documento" => "simple-article"
  "crossmark" => 1
  "subdocumento" => "cor"
  "cita" => "Actas Dermosifiliogr. 2017;108:606"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 615
    "formatos" => array:3 [
      "EPUB" => 37
      "HTML" => 420
      "PDF" => 158
    ]
  ]
  "Traduccion" => array:1 [
    "es" => array:19 [
      "pii" => "S0001731017302107"
      "issn" => "00017310"
      "doi" => "10.1016/j.ad.2017.04.008"
      "estado" => "S300"
      "fechaPublicacion" => "2017-09-01"
      "aid" => "1678"
      "copyright" => "AEDV"
      "documento" => "simple-article"
      "crossmark" => 1
      "subdocumento" => "cor"
      "cita" => "Actas Dermosifiliogr. 2017;108:606"
      "abierto" => array:3 [
        "ES" => true
        "ES2" => true
        "LATM" => true
      ]
      "gratuito" => true
      "lecturas" => array:2 [
        "total" => 474
        "formatos" => array:3 [
          "EPUB" => 2
          "HTML" => 343
          "PDF" => 129
        ]
      ]
      "es" => array:10 [
        "idiomaDefecto" => true
        "cabecera" => "<span class="elsevierStyleTextfn">Comentarios Editoriales</span>"
        "titulo" => "Ivermectina oral&#58; recuperando un f&#225;rmaco para el tratamiento de la escabiosis"
        "tienePdf" => "es"
        "tieneTextoCompleto" => "es"
        "paginas" => array:1 [
          0 => array:1 [
            "paginaInicial" => "606"
          ]
        ]
        "titulosAlternativos" => array:1 [
          "en" => array:1 [
            "titulo" => "Oral Ivermectin&#58; Regaining a Drug for the Treatment of Scabies"
          ]
        ]
        "contieneTextoCompleto" => array:1 [
          "es" => true
        ]
        "contienePdf" => array:1 [
          "es" => true
        ]
        "autores" => array:1 [
          0 => array:2 [
            "autoresLista" => "G&#46; Blasco Morente"
            "autores" => array:1 [
              0 => array:2 [
                "nombre" => "G&#46;"
                "apellidos" => "Blasco Morente"
              ]
            ]
          ]
        ]
      ]
      "idiomaDefecto" => "es"
      "Traduccion" => array:1 [
        "en" => array:9 [
          "pii" => "S1578219017301853"
          "doi" => "10.1016/j.adengl.2017.04.003"
          "estado" => "S300"
          "subdocumento" => ""
          "abierto" => array:3 [
            "ES" => true
            "ES2" => true
            "LATM" => true
          ]
          "gratuito" => true
          "lecturas" => array:1 [
            "total" => 0
          ]
          "idiomaDefecto" => "en"
          "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301853?idApp=UINPBA000044"
        ]
      ]
      "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302107?idApp=UINPBA000044"
      "url" => "/00017310/0000010800000007/v2_201708291352/S0001731017302107/v2_201708291352/es/main.assets"
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1578219017301865"
    "issn" => "15782190"
    "doi" => "10.1016/j.adengl.2017.04.004"
    "estado" => "S300"
    "fechaPublicacion" => "2017-09-01"
    "aid" => "1679"
    "copyright" => "Elsevier Espa&#241;a&#44; S&#46;L&#46;U&#46; and AEDV"
    "documento" => "simple-article"
    "crossmark" => 1
    "subdocumento" => "cor"
    "cita" => "Actas Dermosifiliogr. 2017;108:607"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 559
      "formatos" => array:3 [
        "EPUB" => 38
        "HTML" => 413
        "PDF" => 108
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "cabecera" => "<span class="elsevierStyleTextfn">Commentary</span>"
      "titulo" => "Variability in Therapeutic Decision Making&#58; Evaluation of the Validity of an Information and Communication Technology Tool"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "paginas" => array:1 [
        0 => array:1 [
          "paginaInicial" => "607"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "Variabilidad en la toma de decisiones terap&#233;uticas&#46; A prop&#243;sito de la evaluaci&#243;n de la fiabilidad de una herramienta TIC"
        ]
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "F&#46; Rivas Ruiz"
          "autores" => array:1 [
            0 => array:2 [
              "nombre" => "F&#46;"
              "apellidos" => "Rivas Ruiz"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "Traduccion" => array:1 [
      "es" => array:9 [
        "pii" => "S0001731017302119"
        "doi" => "10.1016/j.ad.2017.04.009"
        "estado" => "S300"
        "subdocumento" => ""
        "abierto" => array:3 [
          "ES" => true
          "ES2" => true
          "LATM" => true
        ]
        "gratuito" => true
        "lecturas" => array:1 [
          "total" => 0
        ]
        "idiomaDefecto" => "es"
        "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731017302119?idApp=UINPBA000044"
      ]
    ]
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301865?idApp=UINPBA000044"
    "url" => "/15782190/0000010800000007/v2_201708291348/S1578219017301865/v2_201708291348/en/main.assets"
  ]
  "en" => array:12 [
    "idiomaDefecto" => true
    "cabecera" => "<span class="elsevierStyleTextfn">Commentary</span>"
    "titulo" => "Oral Ivermectin&#58; Regaining a Drug for the Treatment of Scabies"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:1 [
        "paginaInicial" => "606"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "G&#46; Blasco Morente"
        "autores" => array:1 [
          0 => array:3 [
            "nombre" => "G&#46;"
            "apellidos" => "Blasco Morente"
            "email" => array:1 [
              0 => "gonzaloblascomorente&#64;gmail&#46;com"
            ]
          ]
        ]
        "afiliaciones" => array:1 [
          0 => array:2 [
            "entidad" => "Facultativo Especialista de Dermatolog&#237;a M&#233;dico Quir&#250;rgica y Venereolog&#237;a&#44; Hospital de Alta Resoluci&#243;n de Alcal&#225; la Real&#44; Alcal&#225; la Real&#44; Ja&#233;n&#44; Spain"
            "identificador" => "aff0005"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Ivermectina oral&#58; recuperando un f&#225;rmaco para el tratamiento de la escabiosis"
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The article by our colleagues at Hospital Rey Juan Carlos and Hospital La Princesa reminds us of the possibility of using oral ivermectin to treat scabies&#46;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> This treatment is accepted&#44; recognized&#44; and widely used in other countries&#8212;for example&#44; Brazil&#8212;but a commercial formulation is not available in Spain&#46; Therefore&#44; the use of this treatment is limited and it must be specially prepared or requested for use as a foreign medication&#46;</p><p id="par0010" class="elsevierStylePara elsevierViewall">This medication is usually administered as a single 200<span class="elsevierStyleHsp" style=""></span>&#956;g&#47;kg dose&#46; However&#44; this study found that a high percentage of patients required 2 or 3 doses&#46; The authors therefore decided to increase the single dose to 400<span class="elsevierStyleHsp" style=""></span>&#956;g&#47;kg and found that the medication was well tolerated&#46; The 13 patients treated at this dosage were cured and did not require a second dose&#46;</p><p id="par0015" class="elsevierStylePara elsevierViewall">At both dosages&#44; nearly half of the patients had eczematous eruptions as a side effect and required treatment with topical corticosteroids and emollients&#44; as occurs with other treatments for scabies&#46;</p><p id="par0020" class="elsevierStylePara elsevierViewall">Because the sample size &#40;23 patients&#41; was small for such a common disease&#44; further research is advisable in order to confirm the findings of the study&#46; We therefore suggest that the authors continue working in this direction&#46;</p></span>"
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "NotaPie" => array:1 [
      0 => array:2 [
        "etiqueta" => "&#9734;"
        "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as&#58; Blasco Morente G&#46; Ivermectina oral&#58; recuperando un f&#225;rmaco para el tratamiento de la escabiosis&#46; Actas Dermosifiliogr&#46; 2017&#59;108&#58;606&#46;</p>"
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "Reference"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:1 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1"
              "referencia" => array:1 [
                0 => array:3 [
                  "comentario" => "pii&#58; S0001-7310&#40;17&#41;30131-X&#46; &#91;Article in English&#44; Spanish&#93;"
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Treatment of Human Scabies with Oral Ivermectin&#46; Eczematous Eruptions as a New Non-Reported Adverse Event"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "J&#46; Sanz-Navarro"
                            1 => "C&#46; Feal"
                            2 => "E&#46; Dauden"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.ad.2017.02.011"
                      "Revista" => array:2 [
                        "tituloSerie" => "Actas Dermosifiliogr"
                        "fecha" => "2017"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/15782190/0000010800000007/v2_201708291348/S1578219017301853/v2_201708291348/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "66476"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Commentaries"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010800000007/v2_201708291348/S1578219017301853/v2_201708291348/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219017301853?idApp=UINPBA000044"
]
Compartir
Información de la revista
Vol. 108. Núm. 7.
Páginas 606 (septiembre 2017)
Vol. 108. Núm. 7.
Páginas 606 (septiembre 2017)
Commentary
Acceso a texto completo
Oral Ivermectin: Regaining a Drug for the Treatment of Scabies
Ivermectina oral: recuperando un fármaco para el tratamiento de la escabiosis
Visitas
6842
G. Blasco Morente
Facultativo Especialista de Dermatología Médico Quirúrgica y Venereología, Hospital de Alta Resolución de Alcalá la Real, Alcalá la Real, Jaén, Spain
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo

The article by our colleagues at Hospital Rey Juan Carlos and Hospital La Princesa reminds us of the possibility of using oral ivermectin to treat scabies.1 This treatment is accepted, recognized, and widely used in other countries—for example, Brazil—but a commercial formulation is not available in Spain. Therefore, the use of this treatment is limited and it must be specially prepared or requested for use as a foreign medication.

This medication is usually administered as a single 200μg/kg dose. However, this study found that a high percentage of patients required 2 or 3 doses. The authors therefore decided to increase the single dose to 400μg/kg and found that the medication was well tolerated. The 13 patients treated at this dosage were cured and did not require a second dose.

At both dosages, nearly half of the patients had eczematous eruptions as a side effect and required treatment with topical corticosteroids and emollients, as occurs with other treatments for scabies.

Because the sample size (23 patients) was small for such a common disease, further research is advisable in order to confirm the findings of the study. We therefore suggest that the authors continue working in this direction.

Reference
[1]
J. Sanz-Navarro, C. Feal, E. Dauden.
Treatment of Human Scabies with Oral Ivermectin. Eczematous Eruptions as a New Non-Reported Adverse Event.
Actas Dermosifiliogr, (2017),
pii: S0001-7310(17)30131-X. [Article in English, Spanish]

Please cite this article as: Blasco Morente G. Ivermectina oral: recuperando un fármaco para el tratamiento de la escabiosis. Actas Dermosifiliogr. 2017;108:606.

Copyright © 2017. Elsevier España, S.L.U. and AEDV
Descargar PDF
Idiomas
Actas Dermo-Sifiliográficas
Opciones de artículo
Herramientas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?